When was Artrya founded?

Artrya was founded in 2018 and raised its 1st funding round 7 years after it was founded.

Where is Artrya located?

Artrya is headquartered in Perth, Australia.

How many employees does Artrya have?

As of Aug 31, 2026, the latest employee count at Artrya is 67.

Is Artrya a funded company?

Artrya is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Feb 14, 2025.

When was the latest funding round of Artrya?

Artrya's latest funding was a $***** Post IPO round on Feb 14, 2025, with participation from 0 investor. Its primary sector is Healthcare IT. In Australia, the Healthcare IT sector has seen $476M in funding in 2026 to date.

Where does Artrya rank among its competitors?

Artrya ranks 8th amongst 55 active competitors, of which 9 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was PulseAI, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of Artrya?

Artrya's top competitors include VerAvanti, egnite and Saigeware Technologies. Among them, PulseAI secured the most recent funding round in January, 2026.

Artrya - 2026 Company Profile, Team, Funding & Competitors

Artrya is a public company based in Perth (Australia), founded in 2018 by John Konstantopoulos. It operates as an AI-based cardiovascular health analysis tool for providers. Artrya has raised an undisclosed amount in funding. The company has 55 active competitors, including 9 funded and 2 that have exited. Its top competitors include companies like VerAvanti, egnite and Saigeware Technologies.

Company Details

AI-based cardiovascular health analysis tool for providers. The company has developed software that assists providers in the detection of coronary artery diseases in patients. It has features for disease identification, data analysis, reporting, and more.

Website: artrya.com
Social
Email ID: *****@artrya.com

Key Metrics

Founded Year

2018

Location

Perth, Australia

Stage

Public

Latest Funding Round

Post IPO, Feb 14, 2025, $*****

Investors

Alium Capital & 1 more

Ranked

8^th among 55 active competitors

Employee Count

67 as on Aug 31, 2026

Similar Companies

OpenEvidence & 2902 more

Exit Details

Public

View Artrya's full profile

Artrya got listed on Nov 26, 2021.

Click here to take a look at Artrya's IPO in detail

Artrya has raised funding over 1 round. Artrya has 2 institutional investors.

Here is the list of recent funding rounds of Artrya:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 14, 2025	8435157	Post IPO	3527111	7655147	3486594	8809233

Access funding benchmarks and valuations. Sign up today!

View details of Artrya's funding rounds and investors

The founders of Artrya is John Konstantopoulos.

Here are the details of Artrya's key team members:

John Konstantopoulos: Co-Founder & Executive - Commercial and Strategy of Artrya.

View details of Artrya's Founder profiles and Board Members

Artrya's employee count trend

Artrya has 67 employees as of Aug 26. Here is Artrya's employee count trend over the years:

Uncover Artrya's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Artrya include VerAvanti, egnite and Saigeware Technologies. Here is the list of Top 10 competitors of Artrya, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	VerAvanti 2012, Redmond (United States), Series B	Innovating intravascular imaging with advanced single-use endoscopes for enhanced patient care	$38.9M	HHS	48/100
2nd	egnite 2021, Aliso Viejo (United States), Unfunded	AI-based cardiac health data analysis software for decision support	-	-	44/100
3rd	Saigeware Technologies 2019, Bengaluru (India), Seed	AI-based decision support tool for cardiac and pulmonary practices	$256K	Ideaspring Capital, SFAL & 4 others	44/100
4th	Pie Medical Imaging 1995, Maastricht (Netherlands), Unfunded	Software solutions for medical diagnostics and interventions	-	-	39/100
5th	PrediSurge 2017, Saint Etienne (France), Series A	Provider of decision making tools for cardiologists	$8.51M	Europa, LIFTT & 2 others	38/100
6th	PulseAI 2019, Belfast (United Kingdom), Seed	AI-based heart screening tool for diagnosis	-	Crick, Ulster University	38/100
7th	Waferchips Techno Solutions 2015, Kollam (India), Seed	Provider of platform for patients with early cardiac symptoms	$117K	CCMB, Kickstartup Advisory Services & 2 others	37/100
8th	Artrya 2018, Perth (Australia), Public	AI-based cardiovascular health analysis tool for providers	-	Alium Capital, NorthStar Impact	37/100
9th	Qianglian Zhichuang 2016, Beijing (China), Series D	Developer of AI-driven solutions for cerebrovascular disease diagnosis and treatment	-	Sequoia Capital, Sunland Fund & 4 others	33/100
10th	Topspin Medical 1999, Lod (Israel), Deadpooled	Intravascular MRI catheter for the coronary arteries	$24.5M	Pitango, Giza Venture Capital & 3 others	32/100